Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Nov 30;136(6):1533–1544. doi: 10.1084/jem.136.6.1533

RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION

Eugene A Cornelius 1
PMCID: PMC2139332  PMID: 4404880

Abstract

When weanling (SJL/J x C57BL/1)F1 hybrid mice were given five weekly-injections of small doses of viable SJL/J spleen cells, so as to induce a graft-versus-host reaction (GVHR), reticulum cell sarcomas were induced in all of the host mice by the 40th day after the first cell injection. Such tumors, on transplantation, were accepted by syngeneic (SJL/J x C57BL/1)F1 and C57BL/1 hosts, but not by SJL/J or NZB mice. Cell-free extracts of SJL/J spleens injected into similar hybrids resulted in identical tumors in all hosts within the same period; the transplantation characteristics were also similar. Normal (SJL/J x C57BL/1)F1 hybrids as well as similar hybrids injected with SJL/J liver or syngeneic F1 spleen cells did not develop tumors. Cell-free preparations of eight tumors induced in F1's by viable SLJ/J spleen cells were injected into newborn (C57BL/1 x A)F1 and C57BL/1 mice: tumors were induced, with seven of eight tumor preparations, with a latent period of 33–49 days. Such tumors were lymphosarcomas, and, in the case of (C57BL/1 x A)F1 hosts, further transplantation revealed that they were antigenically C57BL/1 tumors. These experiments provide conclusive evidence for a viral etiology of GVHR-induced tumors. Furthermore, tumor induction in the GVHR does not appear to depend specifically on an immunological mechanism but is most probably due to release or activation of a sufficient quantity of oncogenic virus within a certain time period in a highly susceptible host. Comparison with radiation induction of viral leukemia in mice revealed similarities in regard to optimal host age and the spacing of administration of the tumor-inducing agent. SJL/J mice carry a type C virus which causes a high incidence of spontaneous Hodgkin-like tumors by 1 yr of age; C57BL/1 mice do not develop lymphomas spontaneously but carry a latent leukemogenic virus. Their hybrid also has a low incidence of spontaneous lymphomas. Based on the results of these and previous experiments, the viruses of these strains of mice appear to be highly synergistic in tumor induction in the GVHR. The SJL/J virus is a powerful oncogenic agent. The C57BL/1 virus may be a helper virus to the SJL/J, but is a more powerful determinant of the antigenic composition of the induced tumors. This suggests that the virus of C57BL/1 mice, when activated, is capable of controlling the C57BL/1 genome. Because of the ease and rapidity of viral tumor induction, the SJL/J and C57BL/1 strains of mice, with their F1 hybrid, should be useful for further study of the mechanisms controlling induction of such tumors.

Full Text

The Full Text of this article is available as a PDF (692.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAESE R. M., MARTINEZ C., GOOD R. A. IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS. J Exp Med. 1964 Feb 1;119:211–224. doi: 10.1084/jem.119.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cole L. J., Nowell P. C. Parental-F1 hybrid bone marrow chimeras: high incidence of donor-type lymphomas. Proc Soc Exp Biol Med. 1970 Jul;134(3):653–657. doi: 10.3181/00379727-134-34854. [DOI] [PubMed] [Google Scholar]
  3. Cornelius E. A. Induction of both host- and donor-type tumors as a result of the graft-versus-host reaction. Transplantation. 1972 Jun;13(6):589–591. doi: 10.1097/00007890-197206000-00006. [DOI] [PubMed] [Google Scholar]
  4. Cornelius E. A. Induction of tumors and autoimmune changes in thymectomized mice. Am J Roentgenol Radium Ther Nucl Med. 1972 Apr;114(4):784–791. doi: 10.2214/ajr.114.4.784. [DOI] [PubMed] [Google Scholar]
  5. DUNN T. B. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst. 1954 Jun;14(6):1281–1433. [PubMed] [Google Scholar]
  6. Fenyö E. M., Grundner G., Klein G., Klein E., Harris H. Surface antigens and release of virus in hybrid cells produced by the fusion of A9 fibroblasts with Moloney Lymphoma cells. Exp Cell Res. 1971 Oct;68(2):323–331. doi: 10.1016/0014-4827(71)90157-1. [DOI] [PubMed] [Google Scholar]
  7. Fujinaga S., Poel W. E., Williams W. C., Dmochowski L. Biological and morphological studies of SJL-J strain reticulum cell neoplasms induced and transmitted serially in low-leukemia-strain mice. Cancer Res. 1970 Mar;30(3):729–742. [PubMed] [Google Scholar]
  8. GROSS L. "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proc Soc Exp Biol Med. 1951 Jan;76(1):27–32. [PubMed] [Google Scholar]
  9. GROSS L. Attempt to recover filterable agent from x-ray induced leukemia. Acta Haematol. 1958 Jun;19(6):353–361. doi: 10.1159/000205455. [DOI] [PubMed] [Google Scholar]
  10. Hays E. F. Development of neoplasia and karyotype analysis in mice with graft-versus-host reaction. Cancer Res. 1972 Feb;32(2):276–279. [PubMed] [Google Scholar]
  11. Hays E. F. Graft-versus-host reactions and the viral induction of mouse lymphoma. Cancer Res. 1972 Feb;32(2):270–275. [PubMed] [Google Scholar]
  12. Igel H., Huebner R. J., Deppa B., Bumgarner S. Rescue of the defective murine sarcoma virus genome by radiation-induced leukemia virus from C57BL mice. Proc Natl Acad Sci U S A. 1967 Nov;58(5):1870–1877. doi: 10.1073/pnas.58.5.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jasmin C., Chermann J. C., Piton C., Mathé G., Raynaud M. Augmentation de l'activité leucémogène après précpiitation par le polyéthylene glycol du virus de Friend. C R Acad Sci Hebd Seances Acad Sci D. 1969 Feb 3;268(5):876–878. [PubMed] [Google Scholar]
  14. KAPLAN H. S., BROWN M. B. A quantitative dose-response study of lymphoid-tumor development in irradiated C 57 black mice. J Natl Cancer Inst. 1952 Aug;13(1):185–208. [PubMed] [Google Scholar]
  15. KLEIN G., KLEIN E. Histocompatibility changes in tumors. J Cell Physiol Suppl. 1958 Dec;52(Suppl 1):125–168. doi: 10.1002/jcp.1030520409. [DOI] [PubMed] [Google Scholar]
  16. Kaplan H. S. On the natural history of the murine leukemias: presidential address. Cancer Res. 1967 Aug;27(8):1325–1340. [PubMed] [Google Scholar]
  17. Lapp W. S., Möller G. Prolonged survival of H-2 incompatible skin allografts on F1 animals treated with parental lymphoid cells. Immunology. 1969 Sep;17(3):339–344. [PMC free article] [PubMed] [Google Scholar]
  18. TYLER A. Clues to the etiology, pathology, and therapy of cancer provided by analogies with transplantation disease. J Natl Cancer Inst. 1960 Dec;25:1197–1229. [PubMed] [Google Scholar]
  19. Tennant J. R. Immunogenetic approach to neoplasia. Transplant Proc. 1970 Mar;2(1):104–116. [PubMed] [Google Scholar]
  20. Todaro G. J., Huebner R. J. N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci U S A. 1972 Apr;69(4):1009–1015. doi: 10.1073/pnas.69.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yumoto T., Dmochowski L. Light and electron microscope studies of organs and tissues of SJL-J strain mice with reticulum cell neoplasms resembling Hodgkin's disease. Cancer Res. 1967 Nov;27(11):2098–2112. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES